Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Bohr

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Clinical Oral Investigations|September 3, 2020
A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2Maximilian J Gottsauner, Ioannis Michaelides, Barbara Schmidt, et al.
Frontiers in Oncology|March 17, 2022
Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel BiomarkerMichael Berszin, Ioannis Michaelides, Julia Siemert, et al.
Angiogenesis|September 21, 2023
Targeting the microenvironment in the treatment of arteriovenous malformationsCaroline T Seebauer, Benedikt Wiens, Constantin A Hintschich, et al.
The European Respiratory Journal|April 19, 2014
SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activationMartin Schicht, Felix Rausch, Susetta Finotto, et al.
Journal for Immunotherapy of Cancer|October 25, 2023
MCT4 blockade increases the efficacy of immune checkpoint blockadeNathalie Babl, Sonja-Maria Decking, Florian Voll, et al.
Frontiers in Oncology|September 3, 2024
De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial)Marlen Haderlein, Jens von der Grün, Panagiotis Balermpas, et al.
The Journal of Clinical Investigation|November 15, 2021
Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasonePeter J Siska, Sonja-Maria Decking, Nathalie Babl, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Clinical Oral Investigations|September 3, 2020
A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2Maximilian J Gottsauner, Ioannis Michaelides, Barbara Schmidt, et al.
Frontiers in Oncology|March 17, 2022
Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel BiomarkerMichael Berszin, Ioannis Michaelides, Julia Siemert, et al.
Angiogenesis|September 21, 2023
Targeting the microenvironment in the treatment of arteriovenous malformationsCaroline T Seebauer, Benedikt Wiens, Constantin A Hintschich, et al.
The European Respiratory Journal|April 19, 2014
SFTA3, a novel protein of the lung: three-dimensional structure, characterisation and immune activationMartin Schicht, Felix Rausch, Susetta Finotto, et al.
Journal for Immunotherapy of Cancer|October 25, 2023
MCT4 blockade increases the efficacy of immune checkpoint blockadeNathalie Babl, Sonja-Maria Decking, Florian Voll, et al.
Frontiers in Oncology|September 3, 2024
De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial)Marlen Haderlein, Jens von der Grün, Panagiotis Balermpas, et al.
The Journal of Clinical Investigation|November 15, 2021
Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasonePeter J Siska, Sonja-Maria Decking, Nathalie Babl, et al.
Pageof 10